CharitÚ Universitaetsmedizin Berlin

EuroHYP-1 Charite Berlin logos NeuroCure Cluster of Excellence Center for Stroke Research Berlin Berlin Stroke Alliance Department of Neurology of the CharitÚ

NeuroCure Clinical Research Center
Center for Stroke Research Berlin
Department of Neurology
CharitÚ Universitaetsmedizin Berlin
CharitÚplatz 1
10117 Berlin
Germany
http://www.neurocure.de/en/clinical-center/home.html 
http://neurologie.med-network.de/en_home.html 
http://www.schlaganfallcentrum.de/index.php?id=147 
http://www.schlaganfallcentrum.de/index.php?id=165

Lead Investigators

Prof. Dr. / MD Andreas Meisel
Head of the Neurological Intensive Care Unit and NeuroCure Cerebrovascular Disease Research Group
+49 30 450 660 026
+40 30 450 560 942
Contact

Prof. Dr. / MD Ulrich Dirnagl
Director of the Department of Experimental Neurology and Center for Stroke Research
+49 30 450 560 134
+49 30 450 560 932
Contact

Project Staff

Dr. / MD Sarah Hoffmann
Assistant doctor / Scientist
+49 30 450 539 733
+49 30 450 539 913
Contact

Dr. / MD Lena Ulm
Assistant doctor / Scientist
+49 30 450 639 726
+49 30 450 539 913
Contact

Dr. / MD Christian Meisel
Head Immunology Lab / Immune Monitoring
+49 30 450 524 038
+49 30 450 524 906
Contact

Dr. / MD Siegfried Kohler
Assistant Doctor / Scientist
+49 30 450 639 723
+49 30 450 539 911
Contact

Dr. / MD Gerhard Jan JungehŘlsing
Consultant Neurologist and Head of Trial Team (SMO) of the Center for Stroke Research Berlin / Trial Conductance
+49 30 8445 4080
+49 30 8445 4090
Contact

Institute Presentation

The Department of Neurology is equally dedicated to comprehensive patient care, teaching and neuroscience research. Located in the heart of Berlin, the Department of Neurology at the CharitÚ has been a major center of neurology and neurological research since the early 19th century. Today, the department has a strong focus on neuroimaging and cerebrovascular disorders. The NeuroCure Clinical Research Center (NCRC) and Center for Stroke Research (CSB) supports researchers in the implementation of clinical studies and thereby makes it possible for patients to have access to new therapies.

TOP